Special Issue "Immunometabolism in Mycobacterium tuberculosis (M.tb) Infection"
Deadline for manuscript submissions: 15 January 2024 | Viewed by 1758
Interests: Mycobacterium tuberculosis pathogenesis; immunometabolism; autophagy
Tuberculosis (TB) is a leading infectious disease killer worldwide and is only second to COVID-19. Mycobacterium tuberculosis, the pathogen that causes TB, has the ability to persist in its host and evade multiple antimicrobial mechanisms. M. tuberculosis infection can result in diverse clinical outcomes such as latent asymptomatic infection, active pulmonary disease, and extrapulmonary manifestations. Global efforts to eradicate TB are marred by an alarming increase in multi-drug resistant infections. Thus, there is a pressing need for an advanced understanding of this disease for the development of novel therapies. Recent years have seen substantial research investigating the impact of cellular metabolism on immunity with respect to M. tuberculosis. How host and pathogen influence cellular metabolism and how these interactions shape infection outcomes are poorly understood.
As the Guest Editor of this Special Issue, I invite you to submit original research articles, short communications, and review articles related to immunometabolism in M. tuberculosis pathogenesis. Research articles and short communications may describe metabolic dysfunction underlying inadequate immune responses to M. tuberculosis infection alone or during comorbidities, and metabolic perturbations and metabolites that enhance immunity against TB. Reviews should present the latest advancements in our understanding of immunometabolic crosstalk during M. tuberculosis infections and address gaps in current knowledge. Future investigations into this evolving discipline will contribute to an improved understanding of M. tuberculosis pathogenesis and aid in the development of TB therapies and biomarkers.
This Special Issue is jointly organized with the Special Issue “Mycobacterial Pathogenesis, Drug Resistance and Intervention Strategies“ in journal Medicina.
Dr. Pallavi Chandra
Dr. Selvakumar Subbian
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- tuberculosis, Mycobacterium tuberculosis